Roffman Miller Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Roffman Miller Associates's LLY Position: Q3 2026 in Review
Roffman Miller Associates increased its Eli Lilly (LLY) stake by 4.7% in Q3 2026, buying an estimated $1.29M and bringing the position to 24,380 shares worth $28.2M. The position accounts for 1.45% of the portfolio, ranked #25.
Roffman Miller Associates first reported a position in LLY in Q2 2020 and has held it in 6 quarters since. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Roffman Miller Associates held 24,380 shares of Eli Lilly worth $28.2M as of Q3 2026.
- Roffman Miller Associates bought 1,091 Eli Lilly shares in Q3 2026, an estimated $1.29M.
- Eli Lilly made up 1.45% of Roffman Miller Associates's portfolio in Q3 2026, its #25 holding.
- Roffman Miller Associates first reported a position in Eli Lilly in Q2 2020 and has held it in 6 quarters since.
- 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Roffman Miller Associates's 13F filing for Q3 2026, filed 19 Oct 2026.